Followers | 8 |
Posts | 2087 |
Boards Moderated | 0 |
Alias Born | 07/31/2006 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 18, 2010 10:55:09 PM
Yes, they do. Those who objectively examine the research know it works. Thousands of research animals have shown this to be true.
NanoViricides operate directly on the viral particles, irrespective of and without the assistance of any immune system action. Therefore, the very, very strong conclusion suggested by all of the research is that the drugs will function identically regardless of what animal they happen to be administered to.
Further, no toxicity has ever been shown in any research study -- none, zip, zero. This is what the formal tox package will very likely show -- non toxic. A NON TOXIC wonder drug!
This stuff will be to the treatment and cure of viral disease what Pennicilin was to the treatment and cure of bacterial disease nearly a century ago. Read what the history books said the medical community's reluctance to accept the value of Penicillin, or even to accept the fundamental concept of the infection model of disease! People resist paradigm change because it's not comfortable. It requires them to think.
You simply do not understand how this works, and you argue your negative outcomes based on that lack of understanding. It really is that simple. Do yourself, and all of us a favor, and do some actual research and learn how this stuff works. The earth is not flat, thunder is not the result of the gods bowling, but NanoViricides does, indeed, represent a fundamental paradigm shift in the treatment and cure of viral disease.
best to all
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM